ResearchTrends in Axillary Lymph Node Dissection After Mastectomy Among Patients With Limited Nodal Burden.
ResearchRisk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.
Jan 4, 2025Journal ArticleShort-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.Written by 1 Roon author & 6 others Via Annals of Surgical Oncology
May 1, 2025Journal ArticleACR Appropriateness Criteria® Imaging of Ductal Carcinoma in Situ (DCIS).Written by 1 Roon author & 14 others Via Journal of the American College of Radiology
ResearchComparison of survival outcomes for patients with Stage III vs de novo Stage IV breast cancer.
ResearchHigh risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.
ResearchERBB2-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer.
Jun 6, 2025Journal ArticleAdjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.Written by 1 Roon author & 8 others Via Annals of Surgical Oncology
ResearchASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage Breast Cancer.
ResearchSurvival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study.
ResearchEvaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study.
May 20, 2025Journal ArticleA Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.Written by 1 Roon author & 16 others Via Annals of Surgical Oncology
ResearchThe association of race and ethnicity with risk-reducing mastectomies in patients with non-BRCA mutations.
Sep 20, 2025Journal ArticleNeoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.Written by 1 Roon author & 8 others Via Annals of Surgical Oncology